[1]. Pittenger MF, Discher DE, Péault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regenerative medicine. 2019;4(1):1-15.
[2]. Vosoughi T, Bagheri M, Hosseinzadeh M, Ehsanpour A, Davari N, Saki N. CD markers variations in chronic lymphocytic leukemia: new insights into prognosis. Journal of Cellular Physiology. 2019;234(11):19420-39.
[3]. D’Arcy MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell biology international. 2019;43(6):582-92.
[4]. Guo KT, SchÄfer R, Paul A, Gerber A, Ziemer G, Wendel HP. A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using highâspecific DNA aptamers. Stem cells. 2006;24(10):2220-31.
[5]. Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Oncotarget. 2015;6(21):18613.
[6]. Mohamed-Ahmed S, Fristad I, Lie SA, Suliman S, Mustafa K, Vindenes H, Idris SB. Adiposederived and bone marrow mesenchymal stem cells: a donor-matched comparison. Stem cell research & therapy. 2018;9(1):1-5.
[7]. Berebichez-Fridman R, Montero-Olvera PR. Sources and clinical applications of mesenchymal stem cells: state-of-the-art review. Sultan Qaboos University Medical Journal. 2018;18(3):e264.
[8]. Ma T. Mesenchymal stem cells: from bench to bedside. World journal of stem cells. 2010;2(2):13.
[9]. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nature reviews
immunology. 2008;8(9):726-36.
[10]. Grisendi G, Bussolari R, Cafarelli L, Petak I, Rasini V, Veronesi E, De Santis G, Spano C, Tagliazzucchi M, Barti-Juhasz H, Scarabelli L. Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer TherapyAdipose Stromal/Stem Cells as TRAIL Vehicles. Cancer research. 2010;70(9):3718-29